MSME (Udyam registered) Ministry of MSME
- Category
- Small (2024-25)
- Udyam number
- UDYAM-MH-33-0084196
Celogen Pharma Private Limited - pharma in Navi Mumbai, Maharashtra, India. FY 2026 financials & compliance.
Revenue · FY 2024
₹31.72 Cr
▲ 1% YoY
Net profit · FY 2024
₹1.59 Cr
Net margin 5%
EBITDA · FY 2024
₹5.51 Cr
EBITDA margin 17.4%
Authorised capital
₹5 Cr
Registered with MCA
Paid-up capital
₹4.81 Cr
Issued & subscribed
Open charges
₹41.69 Cr
Satisfied ₹44.83 Cr
Company age
21 yrs
Est. 2005
Employees · EPFO
27
Provident fund records
About Celogen Pharma Private Limited
Data last updated:
Celogen Pharma Private Limited is a private limited company based in Navi Mumbai, Maharashtra, India. It operates in the drug formulation and development segment of the pharmaceuticals sector. It was incorporated on 13 April 2005 and has been in existence for over 21 years.
The company is registered with the Registrar of Companies (ROC), Mumbai, under CIN U24230MH2005PTC152619. Its GSTIN is 27AABCL1038M1ZH (Maharashtra). The company holds 2 GST registrations, all of them active.
The company has an authorised share capital of ₹5 Cr and a paid-up capital of ₹4.81 Cr. It is led by directors including Vinod Balramsingh Marwaha and Thykoottathil Rajan Matthews.
Its last annual general meeting (AGM) was held on 30 September 2024, and its latest financial statements are for the year ended 31 March 2024. The registered office is at B – 106 Techno City X 4/1 Ttc Area MIDC Mahape, Navi Mumbai, Maharashtra, India – 400705.
As per the financials filed for FY 2024, the company reported a revenue of ₹31.72 Cr, a growth of 1% compared to the previous year. For the same year it recorded a net profit of ₹1.59 Cr (net margin 5%) and EBITDA of ₹5.51 Cr (EBITDA margin 17.4%). Revenue has declined at a compounded annual rate (CAGR) of 1% over three years and 2% over five years.
The company has about 27 employees on its provident fund (EPFO) records. Its group structure includes 1 subsidiary and 1 joint venture.
As per MCA filings, the company has open charges of ₹41.69 Cr and satisfied charges of ₹44.83 Cr on record. Court records list 18 cases involving the company, including 1 filed by the company and 17 filed against it; 5 cases are pending.
Celogen Pharma Private Limited is registered as a small enterprise under the Udyam registration framework (Reg. No. UDYAM-MH-33-0084196). The current compliance status is marked as compliant by the Registrar of Companies. For more details, the company can be reached via its website celogenpharma.com.
Company details
CIN U24230MH2005PTC152619
Registration Number 152619
Incorporation Date 13 April 2005
ROC Mumbai
Listing Status Unlisted
Company Status Active
Date of Last AGM 30 September 2024
Date of Balance Sheet 31 March 2024
Compliance Status Active Compliant
MSME Classification Small
Udyam Registration UDYAM-MH-33-0084196
Key People
Rabi Narayan Nayak Additional Director Vinod Balramsingh Marwaha Director Rajivkumar Janardanprasad Singh Additional Director Recognitions & Rankings of Celogen Pharma
Contact details
Celogen Pharma Private Limited's registered office is in Navi Mumbai, Maharashtra. Its website is celogenpharma.com. Its e-mail address and telephone number are in the company report.
- Email
- Telephone
- Website
- Social Media
- Registered AddressB – 106 Techno City X 4/1 Ttc Area MIDC Mahape, Navi Mumbai, Maharashtra, India – 400705
- IndustryPharma, Drug Formulation & Development
To see the full contact details of Celogen Pharma Private Limited, buy the company report.
Comprehensive company report
Celogen Pharma Private Limited - one report that includes everything
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
₹799 ₹999 20% off excluding 18% GST
Secure checkout · GST invoice included
Business activity
The main business activity of Celogen Pharma is trade. In detail, this covers wholesale trading.
| Main activity group code | Main activity | Business activity code | Business activity | Share of turnover |
|---|---|---|---|---|
| G | Trade | G1 | Wholesale Trading |
To see the full business activity and turnover split of Celogen Pharma Private Limited, buy the company report.
Financials of Celogen Pharma Private Limited
FY 2024 filings availableCelogen Pharma Private Limited reported revenue of ₹31.72 Cr (up 1% YoY) for FY 2024.
Revenue · FY 2024
₹31.72 Cr ▲ 1%
Net profit · FY 2024
₹1.59 Cr margin 5%
EBITDA · FY 2024
₹5.51 Cr margin 17.4%
Compounded Annual Growth Rate (CAGR)
Revenue CAGR growth
1 year
▲ 1%
3 years · compounded
▼ 1%
5 years · compounded
▼ 2%
EBITDA CAGR growth
1 year
▼ 8%
3 years · compounded
▲ 15%
5 years · compounded
▲ 11%
Revenue rose 1% in the latest year, though over five years it has declined at a compounded annual rate (CAGR) of 2%. EBITDA fell 8% in the latest year. Three- and five-year figures are compounded annual growth rates (CAGR): the steady yearly rate that links the first and the last year. All are worked out from the filed statements.
Financial Statement Summary
| Metrics | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 | FY 2019-20 |
|---|---|---|---|---|---|
| Profit and Loss Statement | |||||
| Revenue from Operations | |||||
| Other Income | |||||
| Total Revenue | |||||
| Cost of Materials Consumed | |||||
| Employee Benefit Expense | |||||
| Finance Costs | |||||
| Depreciation and Amortisation | |||||
| Other Expenses | |||||
| Total Expenses | |||||
| EBITDA | ₹5.51 Cr | ||||
| Profit Before Tax | |||||
| Tax Expense | |||||
| Net Profit (PAT) | ₹1.59 Cr | ||||
| Balance Sheet | |||||
| Share Capital | |||||
| Reserves and Surplus | |||||
| Net Worth (Total Equity) | |||||
| Long-term Borrowings | |||||
| Short-term Borrowings | |||||
| Trade Payables | |||||
| Total Liabilities | |||||
| Fixed Assets | |||||
| Investments | |||||
| Inventories | |||||
| Trade Receivables | |||||
| Cash and Bank Balance | |||||
| Total Assets | |||||
Financial Ratios
| Metrics | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 | FY 2019-20 |
|---|---|---|---|---|---|
| Profitability | |||||
| EBITDA Margin | 17.4% | ||||
| Net Profit Margin | 5% | ||||
| Return on Equity (ROE) | |||||
| Return on Capital Employed (ROCE) | |||||
| Return on Assets (ROA) | |||||
| Liquidity and Debt | |||||
| Current Ratio | |||||
| Quick Ratio | |||||
| Debt-to-Equity Ratio | |||||
| Interest Coverage Ratio | |||||
| Efficiency and Growth | |||||
| Asset Turnover | |||||
| Receivable Days | |||||
| Payable Days | |||||
| Inventory Days | |||||
| Revenue Growth | |||||
| Net Profit Growth | |||||
To see the full financial statements and ratios of Celogen Pharma Private Limited, buy the company report.
Board of directors of Celogen Pharma Private Limited
Celogen Pharma has 5 current directors and 7 former directors. Current directors are listed first, with their designation and appointment date.
Current Directors
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Rabi Narayan Nayak Also directs: Agam and Gem Laboratories Private Limited, Gpax Pharmaceuticals Private Limited, Celogen Laboratories Private Limited and 2 more | Additional Director | 28 May 2025 | 1 Years 4 Months | Current |
| Vinod Balramsingh Marwaha | Director | 01 May 2024 | 2 Years 5 Months | Current |
| Rajivkumar Janardanprasad Singh Also directs: Raptech Laboratories Private Limited | Additional Director | 30 Apr 2025 | 1 Years 5 Months | Current |
| Thykoottathil Rajan Matthews Also directs: Agam and Gem Laboratories Private Limited, Gpax Pharmaceuticals Private Limited, Celogen Laboratories Private Limited and 1 more | Director | 27 Apr 2005 | 21 Years 5 Months | Current |
| Vijaykumar Vazakttuvaliya Raghavan Nair Also directs: Agam and Gem Laboratories Private Limited, Gpax Pharmaceuticals Private Limited, Celogen Laboratories Private Limited and 2 more | Director | 02 Jul 2007 | 19 Years 3 Months | Current |
Peer comparison
Celogen Pharma Private Limited is compared with the 3 companies closest to it by revenue in the Pharma industry (Formulations), with the same principal business activity (wholesale trading), from the latest filed financials of each company.
| Company | Revenue | Net profit | Margin | Growth (1 yr) | Employees | Location |
|---|---|---|---|---|---|---|
| Celogen Pharma Private Limitedthis company | ₹31.72 Cr (FY 2024) | ₹1.59 Cr | 5% | 1.0% | 27 | Navi Mumbai, Maharashtra, India |
| Proqol Health Care Private Limited | ₹31.67 Cr (FY 2025) | 48.0% | Chennai, Tamil Nadu, India | |||
| KNVM Medicare Private Limited | ₹31.57 Cr (FY 2025) | 31.0% | Ghaziabad, Uttar Pradesh, India | |||
| Novalab Health Care Private Limited | ₹31.54 Cr (FY 2024) | 25.0% | Muzaffarpur, Bihar, India |
To see the full peer comparison of Celogen Pharma Private Limited, buy the company report.
Auditor
Celogen Pharma Private Limited is audited by ANRK & Associates LLP for the financial year 2023.
| Auditor firm | Financial year | Firm registration number |
|---|---|---|
| ANRK & Associates LLP | FY 2023 | W100001 |
Shareholding
The shareholding of Celogen Pharma Private Limited is on record for 5 financial years, the latest being FY 2023, split between promoters, domestic institutions, foreign institutions, public shareholders and others.
| Shareholder category | FY 2023 | FY 2022 | FY 2020 | FY 2019 | FY 2018 |
|---|---|---|---|---|---|
| Promoters | |||||
| Domestic institutional investors (DII) | |||||
| Foreign institutional investors (FII) | |||||
| Public | |||||
| Others |
To see the full shareholding pattern of Celogen Pharma Private Limited, buy the company report.
Charges & borrowings
Open charges
₹41.69 Cr
Satisfied charges
₹44.83 Cr
Breakdown by lending institutions
Latest charge details
| Date | Charge ID | Lender | Amount | Status | Modified or satisfied on |
|---|---|---|---|---|---|
| 26 Nov 2024 | 101019713 | Others | ₹41.69 Cr | Open | |
| 24 Nov 2020 | 100395476 | Abhyudaya Co-Operative Bank Limited | ₹1.5 Cr | Satisfied | |
| 19 Oct 2020 | 100379130 | Abhyudaya Co-Operative Bank Limited | ₹3 Cr | Satisfied | |
| 27 Aug 2020 | 100367133 | Abhyudaya Co-Operative Bank Limited | ₹1 Cr | Satisfied | |
| 16 Mar 2020 | 100331074 | Abhyudaya Co-Operative Bank Limited | ₹3 Cr | Satisfied |
To see the full charge records of Celogen Pharma Private Limited, buy the company report.
Total charge records: 12 View all charges
Legal cases
Celogen Pharma Private Limited has 18 court cases on record: 1 filed by Celogen Pharma, 17 filed against it. 5 cases are pending and 13 are disposed.
Total cases
18
Filed by the company
1
Filed against the company
17
Pending
5
Disposed
13
Cases by court
| Court | Cases | Against the company | Pending |
|---|---|---|---|
| District courts | 13 | 13 | 4 |
| NCLT | 3 | 3 | 0 |
| High courts | 2 | 1 | 1 |
Cases on record (5 of 18)
| Court | Type of case | Party | Status |
|---|---|---|---|
| District court, Thane, Maharashtra | Court case (Reg Dkst) | Filed against the company by Lyrus Life Sciences Pvt Ltd Through Mr Dasari Ramesh | Pending |
| NCLT, Mumbai | Insolvency matter | Filed against the company by Sudeep Pharma Private Limited | Disposed |
| NCLT, Mumbai | Insolvency matter | Filed against the company by Shree Arun Packaging Company Private Limited | Disposed |
| NCLT, Mumbai | Insolvency matter | Filed against the company by M/S. Transglobal Logistics Pvt. Ltd. | Disposed |
| District court, Mumbai CMM Courts, Maharashtra | Court case (Ss cases s) | Filed against the company by M/S. Scorpion Containers Pvt. Ltd. | Disposed |
To see the full case history of Celogen Pharma Private Limited, buy the company report.
Case records are compiled from court listings and may lag the court's own records. A case filed against a company is not a finding against it.
MSME payment delays
Celogen Pharma Private Limited has 6 MSME Form 1 returns on record between 2019 and 2024, listing 101 overdue payments to 23 micro and small suppliers. Companies must report dues to micro and small suppliers that stay unpaid for more than 45 days in a half-yearly MSME Form 1 return.
Suppliers with reported dues (5 of 23)
| Supplier | Amount due | Due since | Reported on |
|---|---|---|---|
| Olive Health Care | |||
| Adiraj Paper Products Private Limited | |||
| Emil Pharmaceutical Industries Private Limited | |||
| Jagatguru Printing Private Limited | |||
| Mitsu Life Science Private Limited |
To see the full MSME payment records of Celogen Pharma Private Limited, buy the company report.
Individuals and sole proprietors among the suppliers are not named.
Group structure & subsidiaries
Celogen Pharma has 1 subsidiary company, 1 joint venture, and 1 associated company. This group structure data is as of FY 2023. The table lists each entity with its relationship and holding.
1
Subsidiary companies
1
Joint ventures
1
Associated companies
Key subsidiaries
| Company Name | CIN | Shares held |
|---|---|---|
| Agam and Gem Laboratories Private Limited | U24232DD1995PTC001997 |
To see the full group structure of Celogen Pharma Private Limited, buy the company report.
Employees & EPFO
Celogen Pharma Private Limited has a workforce of 27 employees on its EPFO records as of Apr 05, 2024, across 1 active EPFO establishment.
Employee count
27
Active EPFO establishments
1
Employee growth
-44.9%
GST
Celogen Pharma has 2 GST registrations: 2 active.
Total GSTINs
2
Active
2
| GSTIN | State | Status | Registered on |
|---|---|---|---|
| 27AABCL1038M1ZH | Maharashtra | Active | 01 Jul 2017 |
| 30AABCL1038M1ZU | Goa | Active | 14 Feb 2025 |
To see the full GST registrations and return filing status of Celogen Pharma Private Limited, buy the company report.
Recent activity
Celogen Pharma Private Limited has 12 board changes on record since 2005: 6 appointments and 6 cessations. The latest: Rabi Narayan Nayak was appointed as Additional Director on 28 May 2025.
Appointed
Rabi Narayan Nayak was appointed as Additional Director.
Appointed
Rajivkumar Janardanprasad Singh was appointed as Additional Director.
Charges
A charge registered on 26 Feb 2020 via Charge ID 100327222 with Abhyudaya Co-Operative Bank Limited was fully satisfied on 07 Feb 2025.
Charges
A charge with Others amounted to Rs. 41.69 Cr with Charge ID 101019713 was registered on 26 Nov 2024.
AGM
Celogen Pharma Private Limited last Annual general meeting of members was held on 30 Sep 2024 as per latest MCA records.
Ceased
Vinod Balramsingh Marwaha ceased to be Additional Director.
Ceased
Rabi Narayan Nayak ceased to be Director.
Appointed
Vinod Balramsingh Marwaha was appointed as Director.
Filing
Celogen Pharma Private Limited has filed its annual Financial statements for the year ended 31 Mar 2024 with Roc Mumbai.
Charges
A charge registered on 24 Nov 2020 via Charge ID 100395476 with Abhyudaya Co-Operative Bank Limited was fully satisfied on 26 Dec 2023.
Charges
A charge registered on 19 Oct 2020 via Charge ID 100379130 with Abhyudaya Co-Operative Bank Limited was fully satisfied on 26 Dec 2023.
Charges
A charge registered on 16 Mar 2020 via Charge ID 100331074 with Abhyudaya Co-Operative Bank Limited was fully satisfied on 26 Dec 2023.
28 earlier events are in the company report.
Frequently asked questions
Celogen Pharma is an active private limited company based in Navi Mumbai, Maharashtra, India. The company works in drug formulation and development, within the pharma industry. It was incorporated on 13 April 2005 (21+ years old) and is registered under CIN U24230MH2005PTC152619.
Celogen Pharma has 5 current directors:
- Rabi Narayan Nayak - Additional Director
- Vinod Balramsingh Marwaha - Director
- Rajivkumar Janardanprasad Singh - Additional Director
- Thykoottathil Rajan Matthews - Director
- Vijaykumar Vazakttuvaliya Raghavan Nair - Director
The latest financial statements of Celogen Pharma on record with the MCA are for the year ended 31 March 2024. Its last annual general meeting was held on 30 September 2024. Year-wise statements from 2015 are in the company report.
The GSTIN of Celogen Pharma is 27AABCL1038M1ZH, registered in Maharashtra. The company has 2 GST registrations in all, of which 2 are active. Other active GSTINs include 30AABCL1038M1ZU (Goa).
The CIN (Corporate Identification Number) of Celogen Pharma is U24230MH2005PTC152619. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
Celogen Pharma has 18 court cases on record: 1 filed by the company and 17 filed against it. 5 are pending. Most are in the district courts.
Celogen Pharma was incorporated on 13 April 2005, making it 21+ years old. It is registered with the Registrar of Companies, Mumbai.
The peers of Celogen Pharma by revenue are Proqol Health Care Private Limited, KNVM Medicare Private Limited, Novalab Health Care Private Limited, all in the Pharma industry (Formulations), with the same principal business activity (wholesale trading).
Rabi Narayan Nayak was appointed as Additional Director on 28 May 2025. Rajivkumar Janardanprasad Singh was appointed as Additional Director on 30 Apr 2025. Vinod Balramsingh Marwaha ceased to be Additional Director on 29 Sep 2024. Celogen Pharma has 12 board changes on record in total.
Yes, Celogen Pharma is registered as a small enterprise under Udyam registration (number: UDYAM-MH-33-0084196).
Celogen Pharma has 6 MSME Form 1 returns on record between 2019 and 2024, listing 101 overdue payments to 23 micro and small suppliers. The latest return was filed on 30 Apr 2024.
Celogen Pharma can be reached through the website celogenpharma.com. Its registered office is in Navi Mumbai, Maharashtra, India.